(Isstories Editorial):- Ramey, United States Mar 12, 2025 (Issuewire.com) – GenPharmaChain, a pioneering blockchain-based AI pharmaceutical research platform, has successfully secured $500,000 in its pre-seed funding round. The investment was led by M2M Capital (@M2MCapital), FNODE Venture (@FNodeVenture), Pharma Lab (@Pharmalab700), and Avatia Pharmaceutical Company, with strategic support from Google, AWS and several angel investors from top-tier Web3 exchanges and VC
Through its decentralized network, GenPharmaChain incentivizes developers to refine AI-driven pharmaceutical models. Scientists and individuals can integrate AI modules to simulate drug interactions, facilitating groundbreaking biomedical research. Early investors have the opportunity to support high-potential AI models, with increased rewards when these models contribute to successful drug pipelines.
More on Isstories:
- America’s Best in Medicine Profiles Dr. Omar Abderhman, DC CME Leading Physician Advancing Multidisciplinary Injury Care
- America’s Top Medicine Profiles Kailyn Elliott: Patient-Centered Innovation in Healthcare, Genomics, and Literature
- Risk Consulting Services, Inc. Expands Canadian Presence with Actuarial Support for Insurance Oversight
- Factory Insights: How Pingwei Designs High-Quality Tool Storage Drawer Trays for Pickup Trucks
- LEELEN as a Custom Whole House Smart Solutions Provider at ISAF 2025: Innovation and Customization
GenPharmaChain is redefining pharmaceutical research with its Decentralized Scientific AI (DeSAI) modeling framework. By aggregating AI-driven drug development models and enabling scientists to combine modular AI units into comprehensive drug pipelines, the platform enhances both AI model efficiency and pharmaceutical value chains.With a robust database of over 80,000 protein records, 4,000 drug profiles, and 98 million data points, GenPharmaChain ensures high accuracy in AI model validation. Key innovations include:
AI-ADMET Testing – Predicting small molecule absorption, metabolism, and toxicity through molecular structure analysis.
AI-Powered Protein Structure Prediction – Identifying drug targets and accelerating drug discovery.
Source :https://x.com/Genpharmachain/status/1899375317187522612 https://x.com/M2MCapital/status/1899377215370088605 https://x.com/FNodeVenture
This article was originally published by IssueWire. Read the original article here.
